Related Experiment Videos
[Venous thrombosis. Experience in treatment, problems and perspectives]
O F Cormaci1, G Carrà, V Sangrigoli
1Divisione di Chirurgia Vascolare, Azienda Ospedaliera Garibaldi, Catania.
Minerva Cardioangiologica
|July 25, 1998
Summary
Early heparin therapy and comprehensive diagnosis are crucial for managing venous thromboembolic disease. Vena cava filters offer limited benefit, and fibrinolytic therapy should be reserved for severe cases with low hemorrhage risk.
Area of Science:
- Vascular Medicine
- Thrombosis Research
- Clinical Outcomes
Context:
- Venous thromboembolic disease (VTE) is a significant cause of mortality, often misunderstood.
- Treatment strategies for VTE require careful risk-benefit balancing, particularly with pharmacological interventions.
- Limb venous thrombosis and pulmonary embolism necessitate individualized management approaches.
Purpose:
- To evaluate the effectiveness of various treatment strategies for limb venous thrombosis and pulmonary embolism over a seven-year period.
- To analyze the impact of early intervention, diagnostic depth, and specific therapies on patient outcomes.
- To refine clinical guidelines based on personal experience and international data.
Summary:
- Early initiation of heparin therapy and rapid achievement of therapeutic ranges are critical to prevent VTE extension.
- Vena cava filters show limited benefit in improving follow-up clinical findings and may increase pathology extension.
- Comprehensive etiological diagnosis is essential for long-term therapeutic strategy and follow-up in VTE patients.
Impact:
- Optimized heparin therapy protocols can reduce VTE recurrence and extension.
- Judicious use of fibrinolytic therapy, reserved for severe cases and low-risk patients, can improve outcomes.
- A thorough diagnostic workup beyond the acute phase is vital for effective VTE management and prevention.